Neurotech Pharmaceuticals, Inc.
Terry McCurren currently holds the role of Director National Accounts- Market Access at Neurotech Pharmaceuticals, Inc. They have previous experience in the pharmaceutical industry, including roles at Otsuka America, Inc. and Bristol-Myers Squibb. Terry holds a Bachelor of Science degree from John Cook School of Business at Saint Louis University and a Master of Business Administration from William Woods University.
This person is not in any offices
Neurotech Pharmaceuticals, Inc.
Neurotech Pharmaceuticals, Inc. is a privately held biotech company located in Cumberland, Rhode Island. Neurotech has spent years developing the science, technology, team and manufacturing behind NT-501. As a result of a unique partnership and clear direction, we are focused on bringing a long-term treatment to Macular Telangiectasia (MacTel) patients. Our team is focused on bringing to market this treatment designed to slow the progression of MacTel and the vision impairments it causes in patients who don't have another treatment option. Our goal is to help these patients sustain their quality of life.